Reveal Biosciences is a leading provider of advanced tissue technology services and tissue-based research. The company’s portfolio includes in situ hybridization (ISH), immunohistochemistry (IHC), immunofluorescence (IF), and histopathology. Reveal enhances these services with proprietary technologies for NGPx™ Next Generation Pathology, multiplexing, whole-slide imaging, and ImageDx™ image analysis software.